Another ADLM has come to a close, and we want to thank everyone who stopped by the Aviva Systems Biology booth to meet with our team.
One of the things we appreciate most about ADLM is the opportunity to have real conversations with researchers, assay developers, diagnostics companies, and industry partners. Every discussion reinforces the same trend: as biomarker research continues to advance, expectations for antibody quality, assay performance, and reproducibility continue to rise.
Throughout the meeting, we shared how Aviva supports these efforts with a growing portfolio of recombinant antibodies, ELISA kits, and custom antibody and assay development services. Whether researchers are evaluating biomarker candidates, developing diagnostic assays, or optimizing existing workflows, our goal remains the same - providing reagents that are thoroughly characterized and built for reliable performance.
We also enjoyed discussing some of our recent technical resources, including:
For those who were unable to attend ADLM this year, many of these resources are available online through our Knowledge Hub.
Trade shows are often the beginning of a conversation. If we met during ADLM and discussed your project, our team will be following up over the coming weeks. If we didn't have the opportunity to connect, we'd still be happy to learn more about your research.
Whether you're looking for a validated antibody, developing a new biomarker assay, or exploring custom antibody discovery, we're always interested in discussing how we can help move your project forward.
Thank you again to everyone who visited our booth. We appreciate the opportunity to be part of the ADLM community and look forward to continuing the conversations that began during the meeting.